Role of the TLR4 pathway in blood-spinal cord barrier dysfunction during the bimodal stage after ischemia/reperfusion injury in rats

Journal of Neuroinflammation

Volumn 11, Issue , 2014, Pages

  Li, Xiao Qian ^a   Lv, Huang Wei ^a   Tan, Wen Fei ^a   Fang, Bo ^a   Wang, He ^a   Ma, Hong ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Blood spinal cord barrier; Myeloid differentiation factor 88; Spinal cord ischemia reperfusion injury; TIR domain containing adaptor inducing IFN ; Toll like receptors 4

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MYELOID DIFFERENTIATION FACTOR 88; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR ADAPTOR MOLECULE 1; ACTIN BINDING PROTEIN; AIF1 PROTEIN, RAT; ANTIOXIDANT; CALCIUM BINDING PROTEIN; ETHYL 6-(N-(2-CHLORO-4-FLUOROPHENYL)SULFAMOYL)CYCLOHEX-1-ENE-1-CARBOXYLATE; GLIAL FIBRILLARY ACIDIC PROTEIN; MICROSOMAL AMINOPEPTIDASE; MYD88 PROTEIN, MOUSE; PEPTIDE; RESVERATROL; STILBENE DERIVATIVE; SULFONAMIDE; TICAM-1 PROTEIN, RAT; VESICULAR TRANSPORT ADAPTOR PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BLOOD SPINAL CORD BARRIER; CELL TYPE; CONTROLLED STUDY; DISEASE ASSOCIATION; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MALE; MICROGLIA; NONHUMAN; PERMEABILITY BARRIER; PROTEIN FUNCTION; RAT; REPERFUSION INJURY; SPINAL CORD INJURY; WESTERN BLOTTING; ANIMAL; CAPILLARY PERMEABILITY; COMPLICATION; DISEASE MODEL; GENE EXPRESSION REGULATION; METABOLISM; PATHOLOGY; PHYSIOLOGY; SIGNAL TRANSDUCTION; SPINAL CORD; SPINAL CORD ISCHEMIA; TIME;

ADAPTOR PROTEINS, VESICULAR TRANSPORT; ANIMALS; ANTIGENS, CD13; ANTIOXIDANTS; CALCIUM-BINDING PROTEINS; CAPILLARY PERMEABILITY; DISEASE MODELS, ANIMAL; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; MICROFILAMENT PROTEINS; MYELOID DIFFERENTIATION FACTOR 88; PEPTIDES; RATS; REPERFUSION INJURY; SIGNAL TRANSDUCTION; SPINAL CORD; SPINAL CORD ISCHEMIA; STILBENES; SULFONAMIDES; TIME FACTORS; TOLL-LIKE RECEPTOR 4;

EID: 84897953397     PISSN: None     EISSN: 17422094     Source Type: Journal    
DOI: 10.1186/1742-2094-11-62     Document Type: Article

References (34)

1. Bell MT, Puskas F, Agoston VA, Cleveland JC, Freeman KA, Gamboni F, Herson PS, Meng X, Smith PD, Weyant MJ, Fullerton DA, Reece TB. Toll-like receptor 4-dependent microglial activation mediates spinal cord ischemia-reperfusion injury. Circulation 2013, 128(1):S152-S156.
2. Zhu P, Li JX, Fujino M, Zhuang J, Li XK. Development and treatment of inflammatory cells and cytokines in spinal cord ischemia-reperfusion injury. Mediators Inflamm 2013, 2013:701970. 3728531, 23956505.
3. Smith PD, Puskas F, Meng XZ, Lee JH, Cleveland JC, Weyant MD, Fullerton DA, Reece TB. The evolution of Chemokine release supports a bimodal mechanism of spinal cord ischemia and reperfusion injury. Circulation 2013, 126(suppl 1):S110-S117.
4. Kahn RA, Stone ME, Moskowita DM. Anesthetic consideration for descending thoracic aortic aneurysm repair. Semin Cardiothorac Vasc Anesth 2007, 11:205-223. 10.1177/1089253207306098, 17711972.
5. Patel VI, Ergul E, Conrad MF, Cambria M, LaMuraglia GM, Kwolek CJ, Brewster DC, Cambria RP. Continued favorable results with open surgical repair of type IV thoracoabdominal aortic aneurysms. J Vasc Surg 2011, 53:1492-1498. 10.1016/j.jvs.2011.01.070, 21514769.
6. Abbott NJ, Rönnbäck L, Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 2006, 7:41-53. 10.1038/nrn1824, 16371949.
7. Matsmumoto S, Matsumoto M, Yamashita A, Ohtake K, Ishida K, Morimoto Y, Sakabe T. The temporal profile of the reaction of microglia, astrocytes, and macrophages in the delayed onset paraplegia after transient spinal cord ischemia in rabbits. Anesth Analg 2003, 96:1777-1784.
8. Fang B, Li XM, Sun XJ, Bao NR, Ren XY, Lv HW, Ma H. Ischemic preconditioning protects against spinal cord ischemia-reperfusion injury in rabbits by attenuating blood spinal cord barrier disruption. Int J Mol Sci 2013, 14:10343-10354. 10.3390/ijms140510343, 3676842, 23685868.
9. Fang B, Wang H, Sun XJ, Li XQ, Ai CY, Tan WF, White PF, Ma H. Intrathecal transplantation of bone marrow stromal cells attenuates blood-spinal cord barrier disruption induced by spinal cord ischemia-reperfusion injury in rabbits. J Vasc Surg 2013, 58:1043-1052. 10.1016/j.jvs.2012.11.087, 23478501.
10. Tanga FY, Nutile-McMenemy N, Deleo JA. The CNS role of toll-like receptor 4 in innate neuroimmunity and painful neuropathy. Proc Natl Acad Sci U S A 2005, 102:5856-5861. 10.1073/pnas.0501634102, 556308, 15809417.
11. Wang J, Hou J, Zhang P, Li D, Zhang C, Liu J. Geniposide reduces inflammatory responses of oxygen-glucose deprived Rat microglial cells via inhibition of the TLR4 signaling pathway. Neurochem Res 2012, 37:2235-2248. 10.1007/s11064-012-0852-8, 22869019.
12. JaJakus PB, Kalman N, Antus C, Radnai B, Tucsek Z, Gallyas F, Sumegi B, Veres B. TRAF6 is functional in inhibition of TLR4-mediated NF-κB activation by resveratrol. J Nutr Biochem 2013, 24:819-823. 10.1016/j.jnutbio.2012.04.017, 22925919.
13. Hanafy KA. The role of microglia and the TLR4 pathway in neuronal apoptosis and vasospasm after subarachnoid hemorrhage. J Neuroinflammation 2013, 10:83. 10.1186/1742-2094-10-83, 3750560, 23849248.
14. Puneet P, McGrath MA, Tay HK, Al-Riyami L, Rzepecka J, Moochhala SM, Pervaiz S, Harnett MM, Harnett W, Melendez AJ. The helminth product ES-62 protects against septic shock via toll-like receptor 4-dependent autophagosomal degradation of the adaptor MyD88. Nat Immunol 2011, 12:344-351.
15. Oshiumi H, Sasai M, Shida K, Fujita T, Matsumoto M, Seya T. TIR-containing adapter molecule (TICAM)-2, a bridging adapter recruiting to toll-like receptor 4 TICAM-1 that induces interferon-β. J Biol Chem 2003, 278:49751-49762. 10.1074/jbc.M305820200, 14519765.
16. Yao AH, Jia LY, Zhang YK, Ma QR, Cheng P, Liu L, Ju G, Kuang F. Early blockade of TLRs MyD88-dependent pathway May reduce secondary spinal cord injury in the rats. Evid Based Complement Alternat Med 2012, 2012:591298. 3364571, 22675384.
17. O'Neill LA, Bowie AG. The family of five: TIR-domain-containing adaptors in toll-like receptor signaling. Nat Rev Immunol 2007, 7:353-364. 10.1038/nri2079, 17457343.
18. Saito O, Svensson CI, Buczynski MW, Wegner K, Hua XY, Codeluppi S, Schaloske RH, Deems RA, Dennis EA, Yaksh TL. Spinal glial TLR4-mediated nociception and production of prostaglandin E (2) and TNF. Br J Pharmacol 2010, 160:1754-1764. 10.1111/j.1476-5381.2010.00811.x, 2936846, 20649577.
19. Gao Y, Fang XB, Sun H, Wang Y, Yao LJ, Li JP, Tong Y, Zhang BH, Liu YL. Toll-like receptor 4-mediated myeloid differentiation factor 88-dependent signaling pathway is activated by cerebral ischemia-reperfusion in hippocampal CA1 region in mice. Biol Pharm Bull 2009, 32:1665-1671. 10.1248/bpb.32.1665, 19801825.
20. Xie XH, Zang N, Li SM, Wang LJ, Deng Y, He Y, Yang XQ, Liu EM. Resveratrol Inhibits respiratory syncytial virus-induced IL-6 production, decreases viral replication, and down regulates TRIF expression in airway epithelial cells. Inflammation 2012, 35:1392-1401. 10.1007/s10753-012-9452-7, 22391746.
21. Lang-Lazdunski L, Matsushita K, Hirt L, Waeber C, Vonsattel JP, Moskowitz MA, Dietrich WD. Spinal cord ischemia. Development of a model in the mouse. Stroke 2000, 31:208-213. 10.1161/01.STR.31.1.208, 10625739.
22. Gong G, Yuan LB, Hu L, Wu W, Yin L, Hou JL, Liu YH, Zhou LS. Glycyrrhizin attenuates rat ischemic spinal cord injury by suppressing inflammatory cytokines and HMGB1. Acta Pharmacol Sin 2012, 33(1):11-18. 10.1038/aps.2011.151, 22158106.
23. Safi HJ, Estrera AL, Miller CC, Huynh TT, Porat EE, Azizzadeh A, Meada R, Goodrick JS. Evolution of risk for neurologic deficit after descending and thoracoabdominal aortic repair. Ann Thorac Surg 2005, 80:2173-2179. 10.1016/j.athoracsur.2005.05.060, 16305866.
24. Papakostas JC, Matsagas MI, Toumpoilis IL, Malamous-Mitsi VD, Pappa LS, Gkrepi C, Anagnostopoulos CE, Kappas AM. Evolution of spinal cord injury in a porcine model of prolonged aortic occlusion. J Surg Res 2006, 133:159-166. 10.1016/j.jss.2005.10.007, 16337967.
25. Tsuruta S, Matsumoto M, Fukuda S, Yamashita A, Cui YJ, Wakamatsu H, Sakabe T. The effects of cyclosporin A and insulin on ischemic spinal cord injury in rabbits. Anesth Analg 2006, 102:1722-1727. 10.1213/01.ane.0000216006.82190.4a, 16717316.
26. Zhang YK, Liu JT, Peng ZW, Fan H, Yao AH, Peng C, Liu L, Ju G, Kuang F. Different TLR4 expression and microglia/ macrophage activation induced by hemorrhage in the rat spinal cord after compressive injury. J Neuroinflammation 2013, 10:112. 10.1186/1742-2094-10-112, 3847110, 24015844.
27. Kim JY, Choi GS, Cho YW, Cho H, Hwang SJ, Ahn SH. Attenuation of spinal cord injury-induced astroglial and microglial activation by repetitive transcranial magnetic stimulation in rats. J Korean Med Sci 2013, 28(2):295-299. 10.3346/jkms.2013.28.2.295, 3565143, 23399872.
28. Costello DA, Lynch MA. Toll-like Receptor 3 activation modulates Hippocampal network excitability, via glial production of interferon-β. Hippocampus 2013, 23(8):696-707. 10.1002/hipo.22129, 23554175.
29. Zughaier SM, Zimmer SM, Datta A, Carlson RW, Stephens DS. Differential induction of the toll-like receptor 4-MyD88-dependent and -independent signaling pathways by endotoxins. Infect Immun 2005, 73:2940-2950. 10.1128/IAI.73.5.2940-2950.2005, 1087371, 15845500.
30. Wang S, Schmaderer C, Kiss E, Schmidt C, Bonrouhi M, Porubsky S, Gretz N, Schaefer L, Kirschning CJ, Popovic ZV, Gröne HJ. Recipient Toll-like receptors contribute to chronic graft dysfunction by both MyD88- and TRIF-dependent signaling. Dis Model Mech 2010, 3:92-103. 10.1242/dmm.003533, 20038715.
31. Fitzgerald KA, Rowe DC, Barnes BJ, Caffrey DR, Visintin A, Latz E, Monks B, Pitha PM, Golenbock DT. LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF. J Exp Med 2003, 198:1043-1055. 10.1084/jem.20031023, 2194210, 14517278.
32. Stroo I, Stokman G, Teske GJ, Raven A, Butter LM, Florquin S, Leemans JC. Chemokine expression in renal ischemia/reperfusion injury is most profound during the reparative phase. Int Immunol 2010, 22:433-442. 10.1093/intimm/dxq025, 2877810, 20410256.
33. Dinarello CA. A clinical perspective of IL-1β as the gatekeeper of inflammation. Eur J Immunol 2011, 41:1203-1217. 10.1002/eji.201141550, 21523780.
34. Akuzawa S, Kazui T, Shi E, Yamashita K, Bashar MA, Terada H. Interleukin-1 receptor antagonist attenuates the severity of spinal cord ischemic injury in rabbits. J Vasc Surg 2008, 48:694-700. 10.1016/j.jvs.2008.04.011, 18572364.